Credit Suisse Ag Allakos Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.13 - $5.55 $36,461 - $95,004	-17,118 Reduced 24.14%	53,781 $122,000
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $79,092 - $115,342	21,970 Added 44.9%	70,899 $309,000
Q1 2023 May 10, 2023	SELL	$4.3 - $8.27 $335 - $645	-78 Reduced 0.16%	48,929 $217,000
Q4 2022 Feb 13, 2023	BUY	$5.66 - $8.42 $277,379 - $412,638	49,007 New	49,007 $412,000
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $64,170 - $151,541	-24,681 Reduced 86.83%	3,744 $12,000
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $7,813 - $15,087	1,538 Added 5.72%	28,425 $162,000
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $1,128 - $14,769	-132 Reduced 0.49%	26,887 $262,000
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $14,387 - $20,760	188 Added 0.7%	27,019 $2.86 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $519,220 - $693,956	6,082 Added 29.31%	26,831 $2.29 Million
Q1 2021 May 14, 2021	SELL	$109.73 - $153.66 $1.81 Million - $2.53 Million	-16,482 Reduced 44.27%	20,749 $2.38 Million
Q4 2020 Feb 12, 2021	BUY	$79.58 - $152.45 $499,682 - $957,233	6,279 Added 20.29%	37,231 $5.21 Million
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $1.17 Million - $1.6 Million	-17,569 Reduced 36.21%	30,952 $2.52 Million
Q2 2020 Aug 12, 2020	SELL	$44.04 - $80.69 $7.28 Million - $13.3 Million	-165,229 Reduced 77.3%	48,521 $3.49 Million
Q1 2020 May 13, 2020	BUY	$44.49 - $93.39 $8.33 Million - $17.5 Million	187,310 Added 708.43%	213,750 $9.51 Million
Q4 2019 Feb 12, 2020	BUY	$66.49 - $137.73 $831,723 - $1.72 Million	12,509 Added 89.79%	26,440 $2.52 Million
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $168,671 - $488,220	5,441 Added 64.09%	13,931 $1.1 Million
Q2 2019 Aug 14, 2019	SELL	$36.0 - $44.73 $16,920 - $21,023	-470 Reduced 5.25%	8,490 $367,000
Q1 2019 May 14, 2019	BUY	$33.79 - $51.99 $136,241 - $209,623	4,032 Added 81.82%	8,960 $363,000
Q4 2018 Feb 13, 2019	BUY	$31.59 - $62.65 $155,675 - $308,739	4,928 New	4,928 $258,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account